Maine regulators have issued a public advisory after laboratory testing identified unsafe mold contamination, alongside other contaminants, in medical cannabis products distributed in the state.
The action highlights the ongoing challenge of mold contamination in the cannabis supply chain, where high-humidity cultivation environments and post-harvest storage can promote fungal growth. Patients using medical cannabis for chronic conditions are often immunocompromised or biotoxin-sensitive, making contamination a meaningful clinical concern.
Details of the affected products and any associated recalls were issued through Maine's medical cannabis program. Patients who purchased the implicated products are advised to follow state guidance.